MBOT — Microbot Medical Income Statement
0.000.00%
- $16.76m
- $10.41m
Annual income statement for Microbot Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.24 | 9.09 | 11.4 | 13.3 | 11 |
Operating Profit | -7.24 | -9.09 | -11.4 | -13.3 | -11 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.25 | -9.17 | -11.3 | -13.2 | -10.7 |
Net Income After Taxes | -7.25 | -9.17 | -11.3 | -13.2 | -10.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.25 | -9.17 | -11.3 | -13.2 | -10.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.25 | -9.17 | -11.3 | -13.2 | -10.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.72 | -1.29 | -1.59 | -1.81 | -0.944 |